Photochemical internalization (PCI) has been employed as a tool for site-specific intracellular delivery of a variety of molecules. In this study, for the first time, PCI has been employed to facilitate the endosomal escape of small interfering RNA (siRNA) molecules, which are the functional mediators of RNA interference (RNAi). In order to interact with the machinery that will induce post-transcriptional gene silencing, siRNA molecules need to enter the cytoplasm of the cells. This study shows that one of the important rate-limiting steps of siRNA silencing efficiency is the ability of siRNA molecules and/or complexes to escape from the endosomes into the cytosol of the cells. The target of this study, the epidermal growth factor receptor (EGFR), is known as an attractive target for cancer therapy. In this study, a 10-fold increased efficiency in knockdown of the EGFR protein was obtained when anti-EGFR siRNA treatment was combined with PCI as compared to siRNA treatment alone. The fact that this combined treatment resulted in a stronger silencing efficiency indicates that lower doses of siRNA can be used when PCI is employed to augment siRNA delivery. Lowering doses of siRNA would prevent saturation of the RNAi machinery and reduce off-target effects. In addition, local illumination of target tissue would only induce PCI in the desired cells, which can further increase the specificity of the treatment, supporting PCI as an attractive strategy to improve siRNA silencing efficiency.
Introduction
The epidermal growth factor receptor (EGFR) is a recognized target for cancer therapy. This transmembrane glycoprotein is known to be overexpressed in many tumors (e.g., colorectal, head and neck, lung, and ovarian carcinomas), and its signaling pathway is involved in cell differentiation, proliferation, migration, development of angiogenesis, and apoptosis inhibition [1] . Furthermore, expression of EGFR is associated with poor treatment responses and fast disease progression. Strategies have been developed to interfere with EGFR signaling; in particular, monoclonal antibodies (mAbs) and tyrosine kinase inhibitors (TKIs) have been broadly explored [2] . Alternative strategies, such as RNA interference (RNAi), aim at reducing the expression of EGFR protein [1] .
Small interfering RNA (siRNA) molecules are the functional mediators of RNAi, a mechanism able to interrupt the translation of a specific protein by inducing post-transcriptional gene silencing. The cleavage of mRNA, induced by siRNA molecules with a complementary sequence, gives the opportunity to design siRNAs that inhibit the expression of specific proteins responsible for pathologies [3] , such as EGFR. Nevertheless, in order to functionally silence EGFR expression, siRNA molecules need to be present in the cytoplasm of the EGFR-expressing tumor cells to interact with the RNAi machinery. The physicochemical properties of siRNA, featured by relatively high molecular weight and strong negative charge, impede cell membrane translocation. As a consequence, a variety of (viral and non-viral) delivery systems have been proposed [3] . Non-viral based carriers, like cationic lipoplexes and polyplexes, are usually taken up by cells through chargebased binding and endocytosis. Once inside the endosomes, these complexes need to efficiently escape into the cytosol, prior to acidification, in order to avoid lysosomal degradation. Some of the carrier materials are known to be able to destabilize the endosomal membrane by themselves, by acting as a proton sponge or a fusogen [4] . Nevertheless, a number of additional mechanisms have been proposed to facilitate the escape of particles from the endosomes, such as photochemical internalization (PCI).
PCI was first presented in 1999 [5] as a novel technology for the delivery of a variety of therapeutic molecules into the cytosol. Since then, several studies have been published, demonstrating that this technique can be used, both in vitro and in vivo [6] [7] [8] , for site-specific delivery of macromolecules, namely proteins [5] , peptides [5] , peptide nucleic acids [9, 10] , and plasmid DNA carried by non-viral [5, 11, 12] and viral-based carrier systems [13] . PCI technology employs specific, preferably amphiphilic [14] , photosensitizing compounds which accumulate in the membranes of the endocytic vesicles. Upon illumination, such photosensitizers (PS) become excited, and subsequently induce the formation of reactive oxygen species, primarily singlet oxygen. This highly reactive intermediate can damage cellular components, but the short range of action and short life-time, confine the damaging effect to the production site. This localized effect induces the disruption of the endocytic vesicles, thereby releasing the entrapped therapeutic molecules into the cytosol [5] .
The aim of this study was to determine whether siRNAmediated silencing of EGFR could be enhanced using PCI as a tool to improve the endosomal escape of anti-EGFR siRNA and, if so, to determine the extent of the silencing improvement.
Materials and methods

Cell line and culture conditions
The human epidermoid carcinoma cell line A431 was kindly given by Dr. Paul M. P. van Bergen en Henegouwen (Institute of Biomembranes, Utrecht University, The Netherlands). A431 cells were subcultured in Dulbecco's modified Eagle's medium containing 3.7 g/l sodium bicarbonate, 4.5 g/l L-glucose (Gibco BRL, Breda, The Netherlands) and supplemented with L-glutamine (2 mM), 7.5% (v/v) foetal bovine serum, penicillin (100 IU/ml), streptomycin (100 μg/ml), and amphotericin B (0.25 μg/ml), at 37°C in a humidified atmosphere containing 5% CO 2 .
Photosensitizer and light source
The photosensitizer (PS) TPPS 2a , meso-tetraphenylporphine with two sulfonate groups on adjacent phenyl rings, was kindly provided by Dr. Anders Høgset (PCI Biotech AS, Oslo, Norway). The PS was light protected and stored at − 20°C until use. Cells were exposed to blue light from the LumiSource®, a bank of four light tubes emitting light in the region of 375-450 nm, with 13 mW/cm 2 irradiance (PCI Biotech AS, Oslo, Norway).
Preparation of siRNA/LF complexes and treatment of cells
Complexes of anti-EGFR siRNA and Lipofectamine (anti-EGFR siRNA/ LF) were prepared by gently mixing 20, 40 and 80 pmol of anti-EGFR siRNA (Eurogentec, Maastricht, The Netherlands) in 50 μl of 5 mM HEPES (pH 7.4), with 1, 2 and 4 μl Lipofectamine (Invitrogen, Breda, The Netherlands) in 50 μl of 5 mM HEPES (pH 7.4), respectively. The solutions were incubated 15 min at room temperature and then added to the cells, resulting in a final concentration of 40, 80 and 160 pmol/ml of anti-EGFR siRNA in the wells. One day after seeding, the cells were incubated with 0.1-1.0 μg/ml PS, in complete culture medium, for 18 h at 37°C. After this, the medium was removed, cells were washed and fresh medium was added to the wells. Thereafter, the anti-EGFR siRNA/LF complexes were added to the cells and incubated for 5 h. Then, the medium was removed, cells were washed and fresh medium was added to the wells. Cells were then exposed to the light source for 60, 75, or 90 s, and then incubated at 37°C for 2 days, after which the EGFR protein expression was analyzed, either by flow cytometry or Western blot.
Complexes of non-specific (NS) siRNA were prepared with anti-Luc siRNA (Qiagen, Venlo, The Netherlands) and Lipofectamine as described above.
Cell proliferation assay
Four thousand cells were seeded per well of 96-well plates and treated as described above, except for the addition of anti-EGFR siRNA/LF complexes. Immediately after illumination of the cells, BrdU reagent was added to the cells and 24 h later the ELISA BrdU-colorimetric immunoassay (Roche Applied Science, Penzberg, Germany) was performed as recommended by the manufacturer. After adding 25 μl of 1 M H 2 SO 4 to interrupt the colorimetric reaction, the absorbance at 450 nm was measured, with the reference wavelength set to 655 nm, using a Bio-Rad Novapath Microplate Reader (Bio-Rad Laboratories, Veenendaal, The Netherlands).
Confocal microscopy
For confocal laser-scanning microscopy analysis, 6 × 10 4 cells were seeded per well of 12-well plates, on gelatine coated (Sigma-Aldrich, Zwijndrecht, The Netherlands) coverslips. The cells were incubated with 0.5 μg/ml of PS and washed as described above. For this experiment the complexes were prepared with Alexa633-labelled siRNA (Eurogentec, Maastricht, The Netherlands) and Lipofectamine, in the same way as described earlier, with a final concentration of 100 pmol/ml of Alexa633-labelled siRNA per well. EGF-Alexa488 (Molecular Probes, Breda, The Netherlands) was added to the wells (0.25 μg/ml) together with the complexes. The cells were fixed with a 4% formaldehyde (Fluka, Zwijndrecht, The Netherlands) solution in PBS, for 30 min at room temperature, after 4-h incubation or few minutes after the 75 s illumination step. After fixation, cells were washed twice with PBS and mounted on glass cover slides, using FluorSave (Calbiochem, San Diego, CA, USA). The cells were then analyzed on a Leica TCS-SP confocal laserscanning microscope (Leica, Heidelberg, Germany) equipped with three lasers: 488-nm argon, 568-nm krypton, and 647-nm HeNe laser.
Flow cytometry analysis
Forty thousand cells were seeded per well of 24-well plates and treated as described earlier. Two days later, the cells were trypsinized, washed with PBA buffer (phosphate-buffered saline supplemented with 0.3% BSA and 0.03% sodium azide) and resuspended in 100 μl PBA buffer. The cells were then incubated with either a specific anti-EGFR monoclonal antibody, or a nonspecific antibody, both labelled with FITC (Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA), for 30 min. Thereafter, the cells were washed twice with PBA, resuspended in 300 μl PBA and analyzed using a FACScalibur (Becton and Dickinson, Mountain View, CA, USA). Dead cells were discriminated from viable cells by adding propidium iodide (Molecular Probes, Breda, The Netherlands) to a final concentration of 1 μg/ml. The data were analyzed with Summit® software (DakoCytomation, Fort Collins, CO, USA) and for relative quantification, the mean fluorescence intensity times the percentage of positive events was used. Generally 10,000 cells were analyzed during each measurement, and samples were prepared in triplicates.
Western blot
Eighty thousand cells were seeded per well of 6-well plates and 48 h after the previously described treatment with anti-EGFR siRNA/LF complexes, cells were lysed with RIPA buffer (50 mM Tris-HCl pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, 1% sodium deoxycholate, 0.1% SDS, containing 1 mM PMSF and 150 μl/ml of complete EDTA-free mini tablet protease inhibitor cocktail (Roche Applied Science, Penzberg, Germany)), for at least 20 min on ice. The lysates were collected and concentrated using centrifugal filters with a molecular weight cut-off of 10 kDa (Microcon, Millipore, Amsterdam, The Netherlands). The total protein content was measured using the Micro BCA assay (Pierce, Rockford, USA), and samples were prepared with 30 mg of total protein, thereafter loaded in each lane of a 7.5% polyacrylamide gel. Electrophoresis was performed at 10-15 mA and subsequently proteins were electrotransferred on a nitrocellulose membrane (Amersham Bioscience, Buckinghamshire, UK), 1 h at 100 mA, with a Scie-Plas semidry blotter (SciePlas, Warwickshire, UK). The non-specific binding to the membrane was blocked using 5% BSA in PBS-T buffer (PBS with 0.1% Tween-20) for 1 h at room temperature, with constant shaking. Thereafter, the membrane was incubated with the primary antibody, rabbit polyclonal anti-EGFR (Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA) at a dilution of 1:250 in PBS-T buffer, followed by incubation with the secondary antibody, goat anti-rabbit antibody labelled with Cy5 dye (Amersham Pharmacia Biotech, Little Chalfont, UK) at a dilution of 1:1250 in PBS-T buffer. For fluorescence visualization, a Typhoon 9400 scanner (Amersham Biosciences, Buckinghamshire, UK) was used. The intensity of the bands was quantified by the ImageQuant 5.0 software (Molecular Dynamics, Sunnyvale, CA, USA).
Results and discussion
In principle, PCI is able to trigger endosomal escape of intact molecules, captured in endocytic vesicles, by disrupting the membrane of these vesicles through photochemical treatment. This technology is preferably performed with amphiphilic PS which accumulate in the membranes of the endocytic vesicles [14] . Preliminary studies confirmed the localization of the PS used in this study, TPPS 2a (meso-tetraphenylporphine with two sulfonate groups), in endocytic vesicles prior to illumination (data not shown). Our preliminary observations are consistent with those reported previously [14] [15] [16] .
To be functional, the PCI technique requires the accumulation of macromolecules inside endocytic vesicles. Confocal microscopy images presented a punctuated fluorescent pattern 4 h after incubation of A431 cells with complexes made of Lipofectamine and Alexa633-labelled siRNA (siRNA-Alexa633/LF) (red vesicles), and with Alexa488-labelled Epidermal Growth Factor (EGF-Alexa488) (green vesicles) (Fig. 1a) . This fluorescent complex of EGF was used to visualize the cellular membrane and endosomes, resulting from the EGF-EGFR complex formation and trafficking. The punctuated pattern, together with several areas where red and green vesicles co-localize (yellow vesicles), indicates the accumulation of the complexes in endocytic vesicles. When illumination is applied after 4-h incubation of A431 cells with siRNA-Alexa633/LF complexes and EGF-Alexa488, a reduction of the punctuated fluorescent pattern is observed (Fig.  1b) . The observed change from punctuated to diffuse fluorescence pattern of Alexa633 (red) throughout the cytoplasm of the cells, suggests the release of siRNA molecules and/or siRNA/LF complexes from the endosomes, as a result of a photo-induced disruption of the endocytic vesicles. This indicates that PCI is a useful tool to facilitate the endosomal escape of siRNA.
The next step was to determine whether PCI, apart from improving the endosomal escape of complexes made of anti-EGFR siRNA and Lipofectamine (anti-EGFR siRNA/LF), would enhance the silencing efficiency of siRNA. The release of the entrapped complexes from the endocytic vesicles is known to be mainly dependent on the intensity of the photochemical reactions (photochemical dose) [17] . Therefore, the amount of photosensitizing compound and the duration of light exposure are decisive variables. Fig. 3 shows the knockdown of EGFR expression, resulting from siRNA-mediated silencing treatment, when combined with different photochemical doses, determined by flow cytometry analysis (Fig. 2a, b) . Increasing concentrations of the photosensitizer employed in PCI, resulted in increased knockdown of the EGFR, up to 70% (Fig. 3a) . The same trend was detected for increasing duration of light exposure (Fig. 3b) . Indeed PCI is able to enhance gene silencing and, in fact, these results confirm that higher photochemical doses induce more efficient release of the complexes from the vesicles.
Increasing photochemical doses can, however, be associated with a higher degree of cytotoxicity. The combination of photosensitizing compounds and light has already been explored in photodynamic therapy (PDT) [18] . In this strategy, a general cytotoxic effect is induced by photochemical reactions in order to eradicate cells. On the contrary, PCI aims at inducing photochemical reactions only in the membranes of endocytic vesicles, for site-specific intracellular delivery. Though, PS usually employed for PCI tend to accumulate in endocytic membranes [14] , a certain cytotoxicity is inevitably associated with PCI. To study the cytotoxicity induced by the photochemical treatment, the proliferation capacity of A431 cells was assessed, at increasing concentrations of PS and increasing intervals of illumination. As expected, higher amounts of photosensitizing compound induced a reduction in cell proliferation and the reduction in cell proliferation was more pronounced for longer illumination intervals (Fig. 4) . No effect was detected when light alone was applied (0.0 μg/ml of PS) and, notably, a low dark toxicity (at 0 s illumination) was associated to the highest PS concentrations (> 0.8 μg/ml of PS).
Since photochemical reactions are, in both PDT and PCI, essential, the determination of the right balance between cytotoxicity and delivery is critical. Obviously, in case of tumor cell treatment, the cytotoxicity induced by PCI is less of a concern, and could even be considered an adjuvant. However, given that the first goal of this study was to evaluate PCI as a tool for improving siRNA delivery into the cytosol, the subsequent experiments were performed employing PCI under conditions that induce a low cytotoxicity, i.e., 0.4 μg/ml PS and 60 s illumination. These conditions (photochemical dose) resulted in a modest reduction of cell proliferation (less than 10%) compared to non-illuminated controls (Fig. 4) . Fig. 5b shows the analysis of Western blot (Fig. 5a ) prepared with cell lysates obtained from samples treated with anti-EGFR siRNA/LF complexes, with and without combination with the PCI technique performed under the conditions mentioned above. Here a 70% knockdown of EGFR expression was obtained when PCI was part of the treatment, compared to 20% knockdown when the treatment consisted of anti-EGFR siRNA/ LF complexes alone. Fig. 5b also shows no significant effect on the expression of EGFR protein for cells subjected to Fig. 2) , is plotted as function of (a) the concentration of PS in μg/ml (for anti-EGFR siRNA/LF complexes with a final concentration of 40 pmol/ml of anti-EGFR siRNA, and 75 s of illumination), and (b) the interval of illumination in seconds (for anti-EGFR siRNA/LF complexes with a final concentration of 40 pmol/ml of anti-EGFR siRNA, and 0.5 μg/ml of PS concentration).
photochemical treatment alone (bar 3), cells treated with free anti-EGFR siRNA (bar 5), and complexes made of non-specific siRNA (bar 6). The increase in silencing efficiency, detected with Western blot, is lower than the enhancement determined by flow cytometry in Fig. 3a (approximately 10% EGFR knockdown for anti-EGFR siRNA/LF complexes alone, and approximately 70% EGFR knockdown when combined with PCI), albeit that flow cytometry analysis was performed after a higher photochemical dose (0.5 μg/ml PS and 75 s illumination). These results, although detected with different techniques, support the notion that PCI has an increased effect when inducing higher cytotoxicity. However, for delivery purposes it is important to avoid higher cytotoxicity and to keep cytotoxicity as lower as possible.
To determine the added value of PCI for siRNA silencing efficiency, three different doses of anti-EGFR siRNA/LF complexes were tested. As shown in Fig. 6b , which was obtained from an analysis of Fig. 6a , the highest concentration of anti-EGFR siRNA, combined with PCI, induced up to 80% knockdown of the EGFR. An equal concentration of anti-EGFR siRNA showed a silencing efficiency of approximately 40% without applying PCI. Additionally, Fig. 6a confirms that the photochemical reactions induced by PCI have no significant effect on the expression of EGFR of non-treated cells, as well as cells incubated with complexes made of non-specific siRNA.
Considering that dose-response curves for anti-EGFR siRNA/LF complexes are likely sigmoidal, it can be calculated that a 50% silencing efficiency is reached when 35 pmol/ml (95% confidence interval 32 to 38 pmol/ml) anti-EGFR siRNA/LF complexes is combined with PCI, whereas 341 pmol/ml (95% confidence interval 317 to 368 pmol/ml) anti-EGFR siRNA/LF complexes are needed to reach 50% silencing without PCI (p < 0.0001 (F-test) ). This corresponds to a PCI-mediated enhancement of silencing efficiency of one order of magnitude. These results contrast favorably with some of the results obtained for PCI experiments with cationic lipids as carriers for plasmid DNA. As previously reported by Høgset et al., the effect of PCI on transfection efficiency of lipidicbased carriers is not as predictable as for polymer-based carriers, where PCI usually has a positive effect (e.g., polylysine, polyethyleneimine) [17] . In the case of transfection with cationic lipids, some of the studies have reported a reduction of transfection efficiency, which seem to vary according to the cell type and lipid composition. In contrast, our results clearly indicate that lipid-complexed nucleic acids are delivered to a higher degree in the cytosol when PCI is applied. This could be explained by the fact that RNAi is processed in the cytoplasm, which, in this case, would be a major advantage, as compared to plasmid DNA for which intracellular trafficking to the nucleus consists of an additional limiting step for transfection to occur.
Taken together, the present study identifies endosomal escape as an important limiting step for siRNA silencing efficiency. Additionally, this study demonstrates that lipidbased carriers of nucleic acids can benefit from PCI, provided that the site of activity of the nucleic acid concerned is localized in the cytoplasm. Importantly, the 10-fold enhancement of silencing efficiency obtained by virtue of the application of PCI, would enable the minimization of siRNA concentrations to . No significant effect was determined by illumination alone (0.0 μg/ml PS), and only a weak dark toxicity (0 s, ○) was associated to the highest PS concentrations.
achieve satisfactory silencing activities. The use of high doses of siRNA has been related to off-target effects [19] and to the saturation of the RNAi machinery, which has already been referred and correlated with a reduction of the degree and the duration of siRNA-mediated silencing [20] . Therefore, any attempt to decrease siRNA concentrations needed for silencing should be taken into account.
One of the major advantages of PCI as a delivery tool is its intracellular site-specific action. The fact that the photochemical-induced delivery of the specific macromolecule is confined only to the illuminated area is an advantage for in vivo studies. siRNA delivery would be limited to the desired cells, thereby further reducing non-specific effects. The major challenge, however, for this technique, is the difficulty of light to deeply penetrate skin. Nevertheless, this has been attenuated by the development of lasers that can be coupled into fiber optics, which in their turn can be inserted into endoscopes. Nowadays, it is possible to illuminate regions in the human body, previously inaccessible, e.g., lungs, gastrointestinal tract, bladder [21] .
This report demonstrates for the first time that PCI can be used to enhance the endosomal escape of anti-EGFR siRNA/LF complexes. The following step will be to determine the applicability of PCI in vivo for enhancing antitumor effects of anti-EGFR siRNA, with limited non-specific effects.
